TrialClinical pharmacokinetics2014

Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.

Celine M Laffont et al.PubMed ↗Publisher ↗

No numbers read from the abstract.